Achuta Kumar Guddati

Associate Professor

  • 504 Citations
  • 8 h-Index
If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Achuta Kumar Guddati is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

Neoplasms Medicine & Life Sciences
Chlorthalidone Medicine & Life Sciences
Ovarian Neoplasms Medicine & Life Sciences
Hydrochlorothiazide Medicine & Life Sciences
Clear Cell Adenocarcinoma Medicine & Life Sciences
Neoplastic Stem Cells Medicine & Life Sciences
Carboplatin Medicine & Life Sciences
oxaliplatin Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2009 2019

  • 504 Citations
  • 8 h-Index
  • 35 Article
  • 4 Letter
  • 3 Review article
1 Citation (Scopus)

Clear cell adenocarcinoma of the lung: A SEER analysis

Komiya, T., Guddati, A. K. & Nakanishi, Y., Apr 1 2019, In : Translational Lung Cancer Research. 8, 2, p. 187-191 5 p.

Research output: Contribution to journalArticle

Clear Cell Adenocarcinoma
SEER Program

Quantitative analysis of desmopressin (DDAVP) response in adult patients with type 1 von Willebrand disease

Guddati, A. K., Rosovsky, R. P., Van Cott, E. M. & Kuter, D. J., Jun 1 2019, In : International Journal of Laboratory Hematology. 41, 3, p. 325-330 6 p.

Research output: Contribution to journalArticle

Type 1 von Willebrand Disease
Deamino Arginine Vasopressin
von Willebrand Factor
Chemical analysis
2 Citations (Scopus)

A phase 3 trial of L-Glutamine in sickle cell disease

Guddati, A. K. & Vamsi Kota, K., Nov 8 2018, In : New England Journal of Medicine. 379, 19, 1 p.

Research output: Contribution to journalLetter

Sickle Cell Anemia

Current and potential targets for drug design in the androgen receptor pathway for prostate cancer

Guddati, A. K., Jun 3 2018, In : Expert Opinion on Drug Discovery. 13, 6, p. 489-496 8 p.

Research output: Contribution to journalReview article

Drug Design
Androgen Receptors
Prostatic Neoplasms
Drug Therapy